Emily Ziedman
Senior Director, Program Management
Karyopharm Therapeutics
Boston, United States
About me
My organisation
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
Speaker sessions (2)
Wednesday, 16 October 2024
16:00 - 16:30
PANEL DISCUSSION: The art and science of decision-making in biotech
- Decision Analysis And Structured Decision Making
This panel discussion will address several approaches of different Pharma and Biotech companies to build a structured decision-making process.
Friday, 18 October 2024
15:00 - 16:00
ROUNDTABLE DISCUSSIONS: E. How to implement learnings from the conference in your organization?
- Break-Out Sessions